France Gets Gene Therapy

by: Patricia Inácio, PhD | July 9, 2024

Hemgenix, the first approved hemophilia B gene therapy, was administered to two patients in France, marking the first time the treatment has been given in Europe. Hemgenix had already been approved in the US and in Canada, and most recently in Switzerland, for patients age 18 and older with severe or moderate hemophilia B. Read more here.

Source: LA Kelley Communications, Inc., Communique, July 2024